Your current web browser is outdated. For best viewing experience, please consider upgrading to the latest version.

Donation - Other Level

Please use the quantity box to donate any amount you wish. Sign Up to Donate

Contact

Send a question or comment using the form below. This message may be routed through support staff.

Email Article

Password Reset Request

Register


Add a topic or expert to your feed.

Following

Follow Experts & Topics

Stay on top of our work by selecting topics and experts of interest.

Experts
Topics
Project
On The Ground

RSVP

event

The Drug-Pricing Challenge

Tom Coburn, MD Nick Ohnell Fellow, MI; Former U.S. Senator
Wed, Jul 19, 2017

Thank you for your RSVP.

ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed

Manhattan Institute

search
Close Nav

The Drug-Pricing Challenge

SEE ALL EVENTS
event

The Drug-Pricing Challenge: Expanding Access, Accelerating Innovation, Growing the Economy

Tom Coburn, MD Nick Ohnell Fellow, MI; Former U.S. Senator
10:00am—12:00pm
Wednesday July 19
Wednesday July 19 2017
PAST EVENT Wednesday July 19 2017

This event is free of charge

America is the world leader in medical innovation, producing medicines that improve and extend the lives of millions of patients at home and abroad. The biotech industry is also one of the U.S.’s economic crown jewels, generating hundreds of thousands of high-paying jobs and billions of dollars in high-value exports.

Misguided remedies to tackle high drug prices, such as price controls and drug importation, will discourage investment in the costly, time-consuming research and development of vital new treatments and cures. Rather than focus on drug prices in a silo, policymakers should explore solutions that ensure that Americans have access to affordable prescription drugs without discouraging innovation.

Solutions include policies that protect U.S. intellectual property overseas, so that other countries contribute to global R&D burdens; tax policies that encourage U.S.-based investment and manufacturing; and regulatory reforms that spur competition, encouraging providers and insurers to seek out technologies that deliver better outcomes for patients. Please join us for a health-care symposium on the drug-pricing challenge.

10:00 - 10:30 AM Reception/Registration
10:30 - 11:00 AM Keynote
Tom Coburn, MI
Jeff Jacoby, Boston Globe
11:00 - 11:45 AM Panel Discussion
Jonathan Davis, Vice-Chair and Chief, Tufts Medical Center
Paul Howard, Director and Senior Fellow, MI
Timothy Hunt, Senior Vice President, Editas Medicine
Kenneth Kaitin, Professor and Director, Tufts University School of Medicine
11:45 AM - 12:00 PM Audience Q&A

 

MEDIA CONTACT

212-599-7000
communications@manhattan-institute.org

TOPICS
Health PolicyDrug Development
Saved!
Close